
Glimfirst MP Forte 2 mg/1000 mg/15 mg Tablet SR
Marketer
Zyphar's Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (1000mg) + Pioglitazone (15mg)
Overview Glimfirst MP Forte 2 mg/1000 mg/15 mg Tablet SR
Glimfirst MP Forte (2 mg/1000 mg/15 mg extended-release tablets) is a triple-combination medication designed to manage blood glucose. This medication, used in conjunction with diet and exercise, enhances glycemic control in adults with type 2 diabetes. It facilitates improved insulin utilization, consequently reducing blood sugar. Adhere strictly to your physician's prescribed dosage and regimen for Glimfirst MP Forte. Ingestion with food is recommended to mitigate gastrointestinal discomfort. Missed doses should be taken promptly, unless nearing the next scheduled dose; in that case, omit the missed dose and resume your regular schedule. Never double the dose. An overdose may cause hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol, or skipped meals increases the risk of hypoglycemia. Regular blood glucose monitoring is crucial. Common adverse effects may encompass nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, inform your doctor of any pre-existing kidney, liver, or heart conditions. Pregnant or lactating individuals must consult their physician before initiating use. Baseline kidney function tests will be performed before treatment commences. Limit alcohol consumption to minimize potential side effects.
Primary Ingredients of Glimfirst MP Forte 2 mg/1000 mg/15 mg Tablet SR
The provided text is "undefined," offering no content to rephrase.
Uses of Glimfirst MP Forte 2 mg/1000 mg/15 mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimfirst MP Forte 2 mg/1000 mg/15 mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimfirst MP Forte 2 mg/1000 mg/15 mg Extended-Release tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.
Common Side effects of Glimfirst MP Forte 2 mg/1000 mg/15 mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimfirst MP Forte 2 mg/1000 mg/15 mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimfirst MP Forte 2 mg/1000 mg/15 mg Sustained-Release Tablets with a meal.
How Glimfirst MP Forte 2 mg/1000 mg/15 mg Tablet SR works:
Glimfirst MP Forte 2 mg/1000 mg/15 mg extended-release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. These medications employ diverse mechanisms to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimfirst MP Forte 2 mg/1000 mg/15 mg SR tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Glimfirst MP Forte 2 mg/1000 mg/15 mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimfirst MP Forte tablet (2 mg/1000 mg/15 mg) is likely not safe for use while breastfeeding. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glimfirst MP Forte 2 mg/1000 mg/15 mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimfirst MP Forte 2 mg/1000 mg/15 mg SR tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Glimfirst MP Forte 2 mg/1000 mg/15 mg SR tablets cautiously, as dose modification may be necessary. Individuals with severe hepatic dysfunction should avoid this medication. Medical advice is recommended.
What if you forget to take Glimfirst MP Forte 2 mg/1000 mg/15 mg Tablet SR :
Should you forget to take a Glimfirst MP Forte 2 mg/1000 mg/15 mg sustained-release tablet, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimfirst MP Forte 2 mg/1000 mg/15 mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
